drugset / Trial / NCT03338569

Vitamin C and Septic Shock

NCT03338569

Phase 2/3 Completed 125 enrolled University of Minnesota
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a randomized, double-blind, placebo-controlled clinical trial to compare Vitamin C versus placebo for patients presenting to the ICU with a diagnosis of septic shock.

Timeline

Start
2017-12-20
Primary completion
2020-06-30
Completion
2020-08-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Vitamin C Other / unclassified 250 mg Intravenous